Induced acute non‐lymphocytic leukemia following long‐term chemotherapy. A study of 20 cases

Twenty individuals developed acute non‐lymphocytic leukemia (ANLL) following long‐term chemotherapy for other disorders. The primary disorders included non‐Hodgkin's lymphoma (five), Hodgkin's disease (five), carcinoma (four), multiple myeloma (three), chronic lymphocytic leukemia (two), and rheumatoid arthritis. Leukemia developed from 11–132 months (mean approximately 60 months) following institution of chemotherapy and all cases have occurred since 1974. Pre‐leukemic cytopenias were present in 15 individuals. Fifteen of the 20 patients had chromosome analyses and 14 were abnormal. The leukemia was invariably refractory to chemotherapy with a median survival of only two months. Of the patients autopsied, only one individual had any evidence of the primary malignancy. This study illustrates the need for surveillance for secondary ANLL following long‐term chemotherapy with/ without radiotherapy. Duration of optimal chemotherapy for the primary disease must be determined by control trials and weighed against the risk of developing a secondary leukemia.

[1]  I. Penn.  Occurrence of cancer in immune deficiencies. , 1982, Cancer.

[2]  J. Rowley,et al.  Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). , 1978, The New England journal of medicine.

[3]  S. Kaplan,et al.  Acute Myelogenous Leukemia Following ImmunosuppressiveTherapy for Rheumatoid Arthritis , 1978 .

[4]  G. D'angio.  Complications of treatment encountered in lymphoma‐leukemia long‐term survivors , 1978, Cancer.

[5]  J. Rowley,et al.  Acute nonlymphocytic leukemia in malignant lymphoma. A morphologic study , 1978, Cancer.

[6]  J. Krause,et al.  Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy , 1978, Cancer.

[7]  E. Glatstein,et al.  Hematologic neoplasia in patients treated for Hodgkin's disease. , 1977, The New England journal of medicine.

[8]  J. Rowley,et al.  Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas , 1977 .

[9]  P. Nowell.  Preleukemia: Cytogenetic Clues in Some Confusing Disorders , 1977 .

[10]  J. Bertino,et al.  Acute nonlymphocytic leukemia. A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases , 1977, Cancer.

[11]  F. Rosner,et al.  Chronic lymphocytic leukemia terminating in acute leukemia. , 1977, New York state journal of medicine.

[12]  B. Chabner.  Second neoplasm--a complication of cancer chemotherapy. , 1977, The New England journal of medicine.

[13]  R. Hoover,et al.  Acute leukemia after alkylating-agent therapy of ovarian cancer. , 1977, The New England journal of medicine.

[14]  R. Myerowitz,et al.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. , 1977, American journal of clinical pathology.

[15]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[16]  C. Harris.  The carcinogenicity of anticancer drugs: A hazard in man , 1976, Cancer.

[17]  I. Penn.  Second malignant neoplasms associated with immunosuppressive medications , 1976, Cancer.

[18]  F. Rosner.  Acute leukemia as a delayed consequence of cancer chemotherapy , 1976, Cancer.

[19]  A. Sandberg,et al.  Chromosomes and causation of human cancer and leukemia. XI. Correlation of karyotypes with clinical features of acute myeloblastic leukemia , 1976, Cancer.

[20]  J. Whang‐Peng,et al.  SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION , 1975, The Lancet.

[21]  F. Rosner,et al.  Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature. , 1975, The American journal of medicine.

[22]  S. L. Schrier,et al.  Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases. , 1974, The American journal of medicine.

[23]  I. Penn.  Chemical immunosuppression and human cancer , 1974, Cancer.

[24]  S. Tolchin,et al.  Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma). , 1974, Arthritis and rheumatism.

[25]  W. Larsen,et al.  Alkylating agents as leukemogens in multiple myeloma , 1974, Cancer.

[26]  S. George,et al.  Clinical implications of aneuploid cyto genetic profiles in adult acute leukemia , 1974, Cancer.

[27]  J. D. Heywood,et al.  Pancytopenia and leukemia in Hodgkin's disease: report of three cases. , 1973, Blood.

[28]  C. Cobau,et al.  Immunosuppressive drugs and acute leukemia. , 1973, Annals of internal medicine.

[29]  P. McKenna,et al.  Acute leukemia complicating metastatic breast cancer , 1973, Cancer.

[30]  B. Kennedy,et al.  Lymphosarcoma terminating in acute myelogenous leukemia , 1972, Cancer.

[31]  D. Catovsky,et al.  Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia. , 1971, Lancet.

[32]  Cornish Cb,et al.  MEDICAL TREATMENT OF OSTEOARTHRITIS. , 1965, Lancet.

[33]  S. Kaplan,et al.  Acute myelogenous leukemia following immunosuppressive therapy for rheumatoid arthritis. , 1978, American journal of clinical pathology.

[34]  J. Rowley.  Chromosomes in leukemia and lymphoma. , 1978, Seminars in hematology.

[35]  R. Kyle,et al.  Multiple myeloma and acute leukemia associated with alkylating agents. , 1975, Archives of internal medicine.

[36]  J. Guignard.  [Immune deficiencies]. , 1974, Maroc medical.